Abstract
Nasopharyngeal carcinoma (NPC) is characterised by its remarkable geographical and ethnic distribution. The interplay between genetic susceptibility, environmental exposures, and Epstein–Barr virus (EBV) infections is indicated in the development of NPC. Exposure to tobacco smoking, dietary factors, and inhalants has been associated with the risk of NPC. Genetic association studies have revealed NPC-associated susceptibility loci, including genes involved in immune responses, xenobiotic metabolism, genome maintenance, and cell cycle regulation. EBV exposure timing and strain variation might play a role in its carcinogenicity, although further investigations are required. Other factors including medical history and oral hygiene have been implicated in NPC. Prevention strategies, including primary prevention and secondary prevention through early detection, are vital in reducing mortality and morbidity of NPC. The current review discusses the global and regional distribution of NPC incidences, the risk factors associated with NPC, and the public health implications of these insights. Future investigations should consider international, large-scale prospective studies to elucidate the mechanisms underlying NPC pathogenesis and develop individualized interventions for NPC.
Similar content being viewed by others
References
Chua, M. L. K., Wee, J. T. S., Hui, E. P., & Chan, A. T. C. (2016). Nasopharyngeal carcinoma. The Lancet, 387(10022), 1012–1024. https://doi.org/10.1016/S0140-6736(15)00055-0
Chen, Y. P., Chan, A. T. C., Le, Q. T., Blanchard, P., Sun, Y., & Ma, J. (2019). Nasopharyngeal carcinoma. The Lancet, 394(10192), 64–80. https://doi.org/10.1016/S0140-6736(19)30956-0
Guo, R., Mao, Y. P., Tang, L. L., Chen, L., Sun, Y., & Ma, J. (2019). The evolution of nasopharyngeal carcinoma staging. The British journal of radiology, 92(1102), 20190244. https://doi.org/10.1259/BJR.20190244
Lai, C., Zhang, C., Lv, H., Huang, H., Ke, X., Zhou, C., & Zhou, L. (2021). A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers. Cancer Medicine, 10(11), 3511. https://doi.org/10.1002/CAM4.3839
Li, J., Chen, S., Peng, S., Liu, Y., Xing, S., He, X., & Chen, H. (2018). Prognostic nomogram for patients with nasopharyngeal carcinoma incorporating hematological biomarkers and clinical characteristics. International Journal of Biological Sciences, 14(5), 549. https://doi.org/10.7150/IJBS.24374
Jen, C.-W., Tsai, Y.-C., Wu, J.-S., Chen, P.-L., Yen, J.-H., Chuang, W.-K., & Cheng, S.H.-C. (2020). Prognostic classification for patients with nasopharyngeal carcinoma based on American Joint Committee on Cancer staging system T and N categories. Therapeutic Radiology and Oncology, 4(0), 2–13. https://doi.org/10.21037/tro.2020.02.01
Wu, Z.-X., Xiang, L., Rong, J.-F., He, H.-L., & Li, D. (2016). Nasopharyngeal carcinoma with headaches as the main symptom: A potential diagnostic pitfall. Journal of Cancer Research and Therapeutics, 12(1), 209–214. https://doi.org/10.4103/0973-1482.157334
Wang, K. H., Austin, S. A., Chen, S. H., Sonne, D. C., & Gurushanthaiah, D. (2017). Nasopharyngeal carcinoma diagnostic challenge in a nonendemic setting: Our experience with 101 patients. The Permanente Journal, 21, 16–180. https://doi.org/10.7812/TPP/16-180
Jiromaru, R., Nakagawa, T., & Yasumatsu, R. (2022). Advanced nasopharyngeal carcinoma: Current and emerging treatment options. Cancer Management and Research, 14, 2681. https://doi.org/10.2147/CMAR.S341472
Ferlay, J, Ervik, M, Lam, F, Laversanne, M, Colombet, M, Mery L, Piñeros, M, Znaor, A, Soerjomataram, I., & Bray, F (2024). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.who.int/today. Accessed 20 Feb 2024
Xie, S. H., Yu, I. T. S., Tse, L. A., Mang, O. W. K., & Yue, L. (2013). Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983–2008: Suggestion of a potential protective role of oestrogen. European Journal of Cancer, 49(1), 150–155. https://doi.org/10.1016/j.ejca.2012.07.004
Zuo, X.-Y., Feng, Q.-S., Sun, J., Wei, P.-P., Chin, Y.-M., Guo, Y.-M., & Bei, J.-X. (2019). X-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma. Biology of Sex Differences, 10(1), 13–24. https://doi.org/10.1186/s13293-019-0227-9
Chen, Y., Chang, E. T., Liu, Z., Liu, Q., Cai, Y., Zhang, Z., & Ye, W. (2021). Residence characteristics and risk of nasopharyngeal carcinoma in southern China: A population-based case-control study. Environment International, 151, 106455. https://doi.org/10.1016/J.ENVINT.2021.106455
London, A. O., Gallagher, L. W., Sharma, R. K., Spielman, D., Golub, J. S., Overdevest, J. B., & Gudis, D. A. (2022). Impact of race, ethnicity, and socioeconomic status on nasopharyngeal carcinoma disease-specific and conditional survival. Seminars in Neurosurgery, 83(5), 451–460. https://doi.org/10.1055/S-0041-1741111
Sung, H., Ferlay, J., Soerjomataram, I., Siegel, R. L., Bray, F., & Jemal, A. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(1), 7–33. https://doi.org/10.3322/caac.21660
Bray, F., Bardot, A., Colombet, M., Mery, L., Pineros, M., Soerjomataram, I., Ferlay, J. (2023). Cancer Incidence in Five Continents, Vol. XII. https://ci5.iarc.who.int/.
Ab Manan, A., Basri, H., Kau, N., Ab Rahman, S. Z., Amir, P. N., Ali, N., Abdul Aziz, A. (2019). Malaysia National Cancer Registry Report 2012–2016. Putrajaya. Retrieved from http://nci.moh.gov.my
Linton, R. E., Daker, M., Khoo, A.S.-B., Chung, Y. C. D., Viljoen, M., & Neilsen, P. M. (2021). Nasopharyngeal carcinoma among the Bidayuh of Sarawak, Malaysia: History and risk factors (Review). Oncology Letters, 22(1), 514–536. https://doi.org/10.3892/ol.2021.12775
Wong, K. Y., Basri, H., Wong, Y. L., Wahab, M., HjKipli, N. P., Niap, I., & Ooi, C. H. (2023). Epidemiology of nasopharyngeal carcinoma in Sarawak, East Malaysia. Asian Pacific Journal of Cancer Prevention, 24, 2817–22. https://doi.org/10.31557/APJCP.2023.24.8.2817
Mathur, P., Sathishkumar, K., Chaturvedi, M., Das, P., Kondalli Sudarshan., L., ... Roselind, F. S. (2020). Cancer Statistics, 2020: Report From National Cancer Registry Programme, India. JCO Global Oncology, 6, 1063–1075. https://doi.org/10.1200/GO.20.00122
Bray, F., Colombet, M., Mery, L., Pineros, M., Znaor, A., Zanetti, R., & Ferlay, J. (2021). Cancer Incidence in Five Continents (Vol. XI). IARC Publications.
Wang, Q., Xie, H., Li, Y., Theodoropoulos, N., Zhang, Y., Jiang, C., & Boffetta, P. (2022). Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans. International Journal of Cancer, 151(8), 1291–1303. https://doi.org/10.1002/ijc.34154
Yu, H., Yin, X., Mao, Y., Chen, M., Tang, Q., & Yan, S. (2021). The global burden of nasopharyngeal carcinoma from 2009 to 2019: An observational study based on the Global Burden of Disease Study 2019. European Archives of Oto-Rhino-Laryngology, 1, 3. https://doi.org/10.1007/s00405-021-06922-2
Carioli, G., Negri, E., Kawakita, D., Garavello, W., La Vecchia, C., & Malvezzi, M. (2017). Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: Focus on low-risk areas. International Journal of Cancer, 140(10), 2256–2264. https://doi.org/10.1002/IJC.30660
Song, Y., Cheng, W., Li, H., & Liu, X. (2022). The global, regional, national burden of nasopharyngeal cancer and its attributable risk factors (1990–2019) and predictions to 2035. Cancer Medicine, 81, 4310. https://doi.org/10.1002/cam4.4783
Noel, C. W., Sutradhar, R., Li, Q., Forner, D., Hallet, J., Cheung, M., & Eskander, A. (2020). Association of immigration status and Chinese and South Asian ethnicity with incidence of head and neck cancer. JAMA Otolaryngology - Head and Neck Surgery, 146(12), 1125–1135. https://doi.org/10.1001/JAMAOTO.2020.4197
Bray, F., Haugen, M., Moger, T. A., Tretli, S., Aalen, O. O., & Grotmol, T. (2008). Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications. Cancer Epidemiology, Biomarkers and Prevention, 17(9), 2356. https://doi.org/10.1158/1055-9965.EPI-08-0461
Lo, K. W., Chung, G. T. Y., & To, K. F. (2012). Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Seminars in Cancer Biology, 22(2), 79–86. https://doi.org/10.1016/j.semcancer.2011.12.011
Liu, Z., Chang, E. T., Liu, Q., Cai, Y., Zhang, Z., Chen, G., & Ye, W. (2017). Quantification of familial risk for nasopharyngeal carcinoma in a high-incidence area. Cancer, 123(14), 2716. https://doi.org/10.1002/CNCR.30643
Poh, S. S., Chua, M. L. K., & Wee, J. T. S. (2016). Carcinogenesis of nasopharyngeal carcinoma: An alternate hypothetical mechanism. Chinese Journal of Cancer, 35(1), 9. https://doi.org/10.1186/S40880-015-0068-9
Yang, -H., Cheng, T.-H., Chen, Y.-F., Lin, C.-S., Gaston, K., Yarbrough, W. G., & Lin, H.-C. (2023). Association of nasopharynx cancer with human papillomavirus infections. Cancers, 15(16), 4082. https://doi.org/10.3390/CANCERS15164082
Huang Lin, J., Pang Wen, C., Qiang Jiang, C., Yuan, J.-M., Jen Chen, C., Yin Ho, S., & Lam, T.-H. (2021). Smoking and nasopharyngeal cancer: Individual data meta-analysis of six prospective studies on 334 935 men. International Journal of Epidemiology, 50(3), 975–986. https://doi.org/10.1093/ije/dyab060
Xue, W.-Q., Qin, H.-D., Ruan, H.-L., Shugart, Y. Y., & Jia, W.-H. (2013). Quantitative association of tobacco smoking with the risk of nasopharyngeal carcinoma: A comprehensive meta-analysis of studies conducted between 1979 and 2011. American Journal of Epidemiology, 178(3), 325–338. https://doi.org/10.1093/aje/kws479
Chang, E. T., Liu, Z., Hildesheim, A., Liu, Q., Cai, Y., Zhang, Z., & Ye, W. (2017). Active and passive smoking and risk of nasopharyngeal carcinoma: A population-based case-control study in southern China. American Journal of Epidemiology, 185(12), 1272–1280. https://doi.org/10.1093/aje/kwx018
Hu, T., Lin, C.-Y., Xie, S.-H., Chen, G.-H., Lu, Y.-Q., Ling, W., & Su-Mei Cao, C. (2019). Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein-Barr virus: An analysis of a prospective study in southern China. Cancer Medicine, 8, 2561–2571. https://doi.org/10.1002/cam4.2083
Arfaeinia, H., Ghaemi, M., Jahantigh, A., Soleimani, F., & Hashemi, H. (2023). Secondhand and thirdhand smoke: A review on chemical contents, exposure routes, and protective strategies. Environmental Science and Pollution Research International, 1, 1. https://doi.org/10.1007/S11356-023-28128-1
Szukalska, M., Szyfter, K., Florek, E., Rodrigo, J. P., Rinaldo, A., Mäkitie, A. A., & Ferlito, A. (2020). Electronic cigarettes and head and neck cancer risk-current state of art. Cancers, 12, 3274. https://doi.org/10.3390/cancers12113274
Okekpa, S. I., Rabiatul Basria S M N Mydin, Mangantig, E., Azmi, N. S. A., Zahari, S. N. S., Kaur, G., & Musa, Y. (2019). Nasopharyngeal carcinoma (NPC) risk factors: A systematic review and meta-analysis of the association with lifestyle, diets, socioeconomic and sociodemographic in Asian Region. Asian Pacific Journal of Cancer Prevention, 20(11), 3505–3514. https://doi.org/10.31557/APJCP.2019.20.11.3505
Feng, R., Chang, E. T., Liu, Q., Cai, Y., Zhang, Z., Chen, G., & Ye, W. (2021). Intake of alcohol and tea and risk of nasopharyngeal carcinoma: A population-based case-control study in southern China. Cancer Epidemiology, Biomarkers and Prevention, 30(3), 545. https://doi.org/10.1158/1055-9965.EPI-20-1244
Secretan, B., Straif, K., Baan, R., Grosse, Y., El Ghissassi, F., & Bouvard, V. (2009). A review of human carcinogens - Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. The Lancet Oncology, 10(11), 1033–1034. https://doi.org/10.1016/S1470-2045(09)70326-2
Barrett, D., Ploner, A., Chang, E. T., Liu, Z., Zhang, C. X., Liu, Q., & Ye, W. (2019). Past and recent salted fish and preserved food intakes are weakly associated with nasopharyngeal carcinoma risk in adults in southern China. Journal of Nutrition, 149(9), 1596–1605. https://doi.org/10.1093/JN/NXZ095
Feng, H., Zhou, Y., Wang, L., Wang, Y., Zhou, S., & Tian, F. (2022). Consumption of processed food and risk of nasopharyngeal carcinoma: A systematic review and meta-analysis. Translational Cancer Research, 11(4), 872–879. https://doi.org/10.21037/TCR-22-690/COIF
Huang, C.-Y., Wu, S.-Y., Hsu, C.-C., & Chou, H.-Y. (2012). The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells. PLoS ONE, 7(9), 44810. https://doi.org/10.1371/journal.pone.0044810
Mai, Z.-M., Kai-Cheong Ngan, R., Lai-Wan Kwong, D., Yuen, K.-T., Kai-Ming Ip, D., Chan, Y.-H., Lam, T.-H. (2021). Dietary fiber intake from fresh and preserved food and risk of nasopharyngeal carcinoma: Observational evidence from a Chinese population. Nutrition Journal, 20, 14. https://doi.org/10.1186/s12937-021-00667-8
Lin, C., Cao, S.-M., Chang, E. T., Liu, Z., Cai, Y., Zhang, Z., & Ye, W. (2019). Chinese nonmedicinal herbal diet and risk of nasopharyngeal carcinoma: A population-based case-control study. Cancer, 125, 4462–4470. https://doi.org/10.1002/cncr.32458
Chen, T., Ricardo Montor, W., Ho, S.-Y., Z-m, M., J-h, L., Rk-c, N., Lam, T.-H. (2019). Milk consumption across life periods in relation to lower risk of nasopharyngeal carcinoma: A multicentre case-control study. Frontiers in Oncology | www.frontiersin.org, 1, 253. https://doi.org/10.3389/fonc.2019.00253
He, Y.-Q., Xue, W.-Q., Shen, G.-P., Tang, L.-L., Zeng, Y.-X., & Jia, W.-H. (2015). Household inhalants exposure and nasopharyngeal carcinoma risk: A large-scale case-control study in Guangdong. China. BMC Cancer, 15, 1022. https://doi.org/10.1186/s12885-015-2035-x
Chen, Y., Chang, E. T., Liu, Q., Cai, Y., Zhang, Z., Chen, G., ... Ye, W. (2021). Occupational exposures and risk of nasopharyngeal carcinoma in a high-risk area: A population-based case-control study. Cancer, 127(15), 2724. https://doi.org/10.1002/cncr.33536
Yang, T., Liu, Y., Zhao, W., Chen, Z., & Deng, J. (2020). Association of ambient air pollution with nasopharyngeal carcinoma incidence in ten large Chinese cities, 2006–2013. International Journal of Environmental Research and Public Health, 17, 6. https://doi.org/10.3390/IJERPH17061824
Meng, E., Yin, J., Jin, W., Mao, Y., Wu, Q., & Qiu, J. (2020). Wood dust exposure and risks of nasopharyngeal carcinoma: A meta-analysis. European Journal of Public Health, 30(4), 817–822. https://doi.org/10.1093/EURPUB/CKZ239
Huang, H.-C., Tantoh, D. M., Hsu, S.-Y., Nfor, O. N., Lin Frank, C.-F., Lung, C.-C., & Liaw, Y.-P. (2020). Association between coarse particulate matter (PM 10–2.5) and nasopharyngeal carcinoma among Taiwanese men. J Investig Med, 68, 419–424. https://doi.org/10.1136/jim-2019-001119
Cao, S.-M., Chen, S.-H., Qian, C.-N., Liu, Q., & Xia, Y.-F. (2014). Familial nasopharyngeal carcinomas possess distinguished clinical characteristics in southern China. Chinese Journal of Cancer Research, 26(5), 543–549. https://doi.org/10.3978/j.issn.1000-9604.2014.10.03
Ouyang, P.-Y., Su, Z., Mao, Y.-P., Liang, X.-X., Liu, Q., & Xie, F.-Y. (2013). Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinoma. British Journal of Cancer, 2013(109), 788–794. https://doi.org/10.1038/bjc.2013.343
Siak, P. Y., Khoo, A.S.-B., Leong, C. O., Hoh, B.-P., & Cheah, S.-C. (2021). Current status and future perspectives about molecular biomarkers of nasopharyngeal carcinoma. Cancers, 13(14), 3490. https://doi.org/10.3390/cancers13143490
Ning, L., Mun-Yee Ko, J., Zhuoyou Yu, V., Yan Ng, H., King-Chi Chan, C., Tao, L., & Li Lung, M. (2020). Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci. Communications Biology, 3, 759. https://doi.org/10.1038/s42003-020-01487-y
Liu, Z., Goldstein, A. M., Hsu, W.-L., Yu, K. J., Chien, Y.-C., Ko, J.-Y., & Hildesheim, A. (2019). Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC. Cancer Epidemiology, Biomarkers and Prevention, 28(10), 1682. https://doi.org/10.1158/1055-9965.EPI-19-0007
Yee Ko, J. M., Dai, W., Wun Wong, E. H., Kwong, D., Ng, W. T., Lee, A., & Li Lung, M. (2014). Multigene pathway-based analyses identify nasopharyngeal carcinoma risk associations for cumulative adverse effects of TERT-CLPTM1L and DNA double-strand breaks repair. International Journal of Cancer, 135(7), 1634–1645. https://doi.org/10.1002/IJC.28802
Wang, T.-M., Xiao, R.-W., He, Y.-Q., Zhang, W.-L., Diao, H., Tang, M., & Jia, W.-H. (2023). High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma. The American Journal of Human Genetics. https://doi.org/10.1016/j.ajhg.2023.06.003
Wu, M.-Y., Huang, S.-J., Yang, F., Qin, X.-T., Liu, D., Ding, Y., & Wang, X.-C. (2017). Detection of nasopharyngeal carcinoma susceptibility with single nucleotide polymorphism analysis using next-generation sequencing technology. Oncotarget, 8(32), 52708–23. https://doi.org/10.18632/oncotarget.17085
Zhuo, X., Ye, H., Li, Q., Xiang, Z., & Zhang, X. (2016). Is MDM2 SNP309 variation a risk factor for head and neck carcinoma? Medicine, 95(9), e2948. https://doi.org/10.1097/MD.0000000000002948
Wu, M., Huang, S., Liu, D., Peng, M., Yang, F., & Wang, X. (2016). Association of the p53 or GSTM1 polymorphism with the risk of nasopharyngeal carcinoma: A meta-analysis. Molecular and Clinical Oncology, 4, 221–228. https://doi.org/10.3892/mco.2015.700
Sahu, S., Chakrabarti, S., Roy, S., Baishya, N., Reddy, R., Suklabaidya, S., & Choudhuri, T. (2016). Association of p53 codon72 Arg>Pro polymorphism with susceptibility to nasopharyngeal carcinoma: Evidence from a case-control study and meta-analysis. Oncogenesis, 5, 225. https://doi.org/10.1038/oncsis.2016.31
Cao, L., Li, P., & Dong, L. (2017). Matrix metalloproteinase-1 (MMP-1) rs1799750 polymorphism is associated with nasopharyngeal carcinoma (NPC) risk. Cellular and Molecular Biology, 63(10), 1–3. https://doi.org/10.14715/cmb/2017.63.10.1
Li, Z., Ge, H., Xie, Y. G., Xie, G. Y., & Lv, C. (2015). Matrix metalloproteinase-1 (MMP1) polymorphism is associated with lowered risk of nasopharyngeal carcinoma in Asian population. Cell Biochemistry and Biophysics, 71(2), 999–1004. https://doi.org/10.1007/s12013-014-0299-4
Zheng, Y., Wang, M., Tian, T., Liu, K., Liu, X., Zhai, Y., & Lu, J. (2017). Role of interleukin-12 gene polymorphisms in the onset risk of cancer: a meta-analysis. Oncotarget, 8(18), 29795–29807.
Xiao, T.-T., Li, X., Xu, Y., & Li, Y. (2018). Significant association of the cytokine variants with head and neck cancer risk: Evidence from meta-analysis. European Archives of Oto-Rhino-Laryngology, 275(3), 483–496. https://doi.org/10.1007/s00405-017-4820-4
Huang, C.-Y., Chang, W.-S., Tsai, C.-W., Hsia, T.-C., Shen, T.-C., Bau, D.-T., & Shui, H.-A. (2018). The contribution of interleukin-8 genotypes and expression to nasopharyngeal cancer susceptibility in Taiwan. Medicine, 97(36), e12135. https://doi.org/10.1097/MD.0000000000012135
Niu, Y., Zhou, G., Wang, Y., Qin, J., Ping, J., Zhang, Q., & Zhou, G. (2019). Association of MCP-1 promoter polymorphism with susceptibility to nasopharyngeal carcinoma. Journal of Cellular Biochemistry, 120(4), 6661–6670. https://doi.org/10.1002/jcb.27962
Zhang, H., Deng, S., Zhang, J., Zhu, G., Zhou, J., Ye, W., & Lu, S. (2021). Single nucleotide polymorphisms within NFKBIA are associated with nasopharyngeal carcinoma susceptibility in Chinese Han population. Cytokine, 138, 155356. https://doi.org/10.1016/j.cyto.2020.155356
Li, Q., Wang, J. M., Peng, Y., Zhang, S. H., Ren, T., Luo, H., & Wang, D. (2013). Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population. Asian Pacific Journal of Cancer Prevention, 14(9), 5145–5151. https://doi.org/10.7314/APJCP.2013.14.9.5145
Wang, T.-M., He, Y.-Q., Xue, W.-Q., Zhang, J.-B., Xia, Y.-F., Deng, C.-M., & Jia, W.-H. (2022). Whole-exome sequencing study of familial nasopharyngeal carcinoma and its implication for identifying high-risk individuals. Journal of the National Cancer Institute, 00(0), djac177. https://doi.org/10.1093/jnci/djac177
Ban, E.-Z., Lye, M.-S., Pei Chong, P., Yap, Y.-Y., Ying Crystale Lim, S., & Abdul Rahman, H. (2017). Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia. PLos One, 12(11), e0187200. https://doi.org/10.1371/journal.pone.0187200
Yu, G., Hsu, W. L., Coghill, A. E., Yu, K. J., Wang, C. P., Lou, P. J., & Goldstein, A. M. (2019). Whole-exome sequencing of nasopharyngeal carcinoma families reveals novel variants potentially involved in nasopharyngeal carcinoma. Scientific Reports, 9(1), 9916. https://doi.org/10.1038/S41598-019-46137-4
Xie, Y., Wu, Y., Zhou, X., Yao, M., Ning, S., & Wei, Z. (2016). Association of polymorphisms hOgg1 rs1052133 and hMUTYh rs3219472 with risk of nasopharyngeal carcinoma in a chinese population. OncoTargets and Therapy, 9, 755–760. https://doi.org/10.2147/OTT.S95944
Lin, J., Ye, Q., Wang, Y., Wang, Y., & Zeng, Y. (2018). Association between XRCC1 single-nucleotide polymorphisms and susceptibility to nasopharyngeal carcinoma: An update meta-analysis. Medicine, 97(32), e11852. https://doi.org/10.1097/MD.0000000000011852
Cui, Q., Zuo, X. Y., Lian, Y. F., Feng, Q. S., Xia, Y. F., He, C. Y., & Bei, J. X. (2016). Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: Evidence from a large-scale case-control study and a meta-analysis. Tumor Biology, 37(11), 14825–14830. https://doi.org/10.1007/s13277-016-5300-y
Wang, T.-M., Zhou, T., He, Y.-Q., Xue, W.-Q., Zhang, J.-B., Zheng, X.-H., ... Jia, W.-H. (2018). Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility. Cancer Medicine, 7, 6308–6316. https://doi.org/10.1002/cam4.1838
Chin, Y.-M., Mushiroda, T., Takahashi, A., Kubo, M., Krishnan, G., Yap, L.-F., & Ng, C.-C. (2015). HLA-A SNPs and amino acid variants are associated with nasopharyngeal carcinoma in Malaysian Chinese. International Journal of Cancer, 136, 678–687. https://doi.org/10.1002/ijc.29035
Tian, W., Zhu, F. M., Wang, W. Y., Cai, J. H., Zhang, W., Li, L. X., & Wang, F. (2015). Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China. Tissue Antigens, 86(1), 15–20. https://doi.org/10.1111/tan.12576
Tian, W., Zhu, F., Cai, J., Li, L., Jin, H., & Wang, W. (2020). Multiple low-frequency and rare HLA-B allelic variants are associated with reduced risk in 1,105 nasopharyngeal carcinoma patients in Hunan province, southern China. International Journal of Cancer, 147, 1397–1404. https://doi.org/10.1002/ijc.32992
Yao, K., Yang, S., Shen, J., Zhang, R., & Li, L. (2017). HLA-DRB1 allele polymorphism and nasopharyngeal carcinoma risk: A meta-analysis. European Archives of Oto-Rhino-Laryngology, 274, 297–303. https://doi.org/10.1007/s00405-016-4264-2
Sun, N., & Wang, X. (2019). Correlation between COX-2 gene polymorphism and susceptibility to nasopharyngeal carcinoma. European Review for Medical and Pharmacological Sciences, 23, 5770–5778.
Fu, J., Li, Z., & Li, N. (2018). The association between COX-2 gene rs5275 polymorphism and nasopharyngeal carcinoma risk. Pathology Research and Practice, 214(10), 1579–1582. https://doi.org/10.1016/j.prp.2018.07.028
Yang, L., Liu, B., Qiu, F., Huang, B., Li, Y., Huang, D., & Lu, J. (2014). The effect of functional MAPKAPK2 copy number variation CNV-30450 on elevating nasopharyngeal carcinoma risk is modulated by EBV infection. Carcinogenesis, 35(1), 46–52. https://doi.org/10.1093/carcin/bgt314
Yang, Z.-H., Dai, Q., Gu, Y.-J., Guo, Q.-X., & Gong, L. (2012). Cytokine and chemokine modification by Toll-like receptor polymorphisms is associated with nasopharyngeal carcinoma. Cancer Science, 103(4), 653–658. https://doi.org/10.1111/j.1349-7006.2012.02210.x
Liao, W.-L., Chan, F.-C., Chang, K.-P., Chang, Y.-W., Chen, C.-H., Su, W.-H., & Chang, H.-H. (2021). Associations between ALDH genetic variants, alcohol consumption, and the risk of nasopharyngeal carcinoma in an East Asian population. Genes, 12, 1547. https://doi.org/10.3390/genes12101547
Singh, S. A., & Ghosh, S. K. (2019). Metabolic phase I (CYPs) and phase II (GSTs) gene polymorphisms and their interaction with environmental factors in nasopharyngeal cancer from the ethnic population of Northeast India. Pathology and Oncology Research, 25(1), 33–44. https://doi.org/10.1007/s12253-017-0309-0
Yao, K., Qin, H., Gong, L., Zhang, R., & Li, L. (2017). CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: A meta-analysis. European Archives of Oto-Rhino-Laryngology, 274, 253–259. https://doi.org/10.1007/s00405-016-4236-6
Li, Y., Wan, W., Li, T., Cao, J., & Xu, G. (2015). GSTMI null genotype may be associated with an increased nasopharyngeal cancer risk in South China: An updated meta-analysis and review. OncoTargets and Therapy, 8, 2479–2484. https://doi.org/10.2147/OTT.S89212
Liu, R.-R., Chen, J.-C., Li, M.-D., Li, T., Tan, Y., & Zhang, M. (2015). A meta-analysis of glutathione S-transferase M1 and T1 genetic polymorphism in relation to susceptibility to nasopharyngeal carcinoma. Int J Clin Exp Med (Vol. 8).
Siew Yong Low, J., Ming Chin, Y., Mushiroda, T., Kubo, M., Krishnan Govindasamy, G., Choo Pua, K., & Ching Ng, C. (2016). A genome wide study of copy number variation associated with nasopharyngeal carcinoma in Malaysian Chinese identifies CNVs at 11q14.3 and 6p21.3 as Candidate Loci. PLoS One, 11(1), e0145774. https://doi.org/10.1371/journal.pone.0145774
Clemente, F. J., Cardona, A., Inchley, C. E., Peter, B. M., Jacobs, G., Pagani, L., & Kivisild, T. (2014). A selective sweep on a deleterious mutation in CPT1A in Arctic populations. The American Journal of Human Genetics, 95(5), 584–589. https://doi.org/10.1016/J.AJHG.2014.09.016
Qin, H.-D., Yao Shugart, Y., Bei, J.-X., Pan, Q.-H., Chen, L., Feng, Q.-S., & Jia, W.-H. (2011). Comprehensive pathway-based association study of DNA repair gene variants and the risk of nasopharyngeal carcinoma. Cancer Research, 71(18), 3000. https://doi.org/10.1158/0008-5472.CAN-10-0469
Mun-Yee Ko, J., Hiu-Ki Tsang, K., Dai, W., Sta Ana Choi, S., Man-Long Leong, M., Kai-Cheong Ngan, R., & Li Lung, M. (2018). Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese. International Journal of Cancer, 143, 2289–2298. https://doi.org/10.1002/ijc.31617
Khan, G., Fitzmaurice, C., Naghavi, M., & Ahmed, L. A. (2020). Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017. British Medical Journal Open, 10(8), e037505. https://doi.org/10.1136/BMJOPEN-2020-037505
Young, L. S., Yap, L. F., & Murray, P. G. (2016). Epstein-Barr virus: More than 50 years old and still providing surprises. Nature Reviews Cancer, 16(12), 789–802. https://doi.org/10.1038/nrc.2016.92
Luo, X., Hong, L., Cheng, C., Li, N., Zhao, X., Shi, F., & Cao, Y. (2018). DNMT1 mediates metabolic reprogramming induced by Epstein-Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma. Cell Death and Disease, 9(6), 619. https://doi.org/10.1038/S41419-018-0662-2
Chen, Y.-R., Liu, M.-T., Chang, Y.-T., Wu, C.-C., Hu, C.-Y., & Chen, J.-Y. (2008). Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells. Journal of Virology, 82(16), 8124. https://doi.org/10.1128/JVI.00430-08
Lung, R. W. M., Hau, P. M., Yu, K. H. O., Yip, K. Y., Tong, J. H. M., Chak, W. P., & Lo, K. W. (2018). EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. Journal of Pathology, 244(4), 394–407. https://doi.org/10.1002/PATH.5018
Pai, S., O’Sullivan, B., Abdul-Jabbar, I., Peng, J., Connoly, G., Khanna, R., & Thomas, R. (2007). Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunology and Cell Biology, 85(5), 370–377. https://doi.org/10.1038/sj.icb.7100046
Yao, M., Ohshima, K., Suzumiya, J., Kume, T., Shiroshita, T., & Kikuchi, M. (1997). Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Journal of Cancer, 72, 398–402. https://doi.org/10.1002/(sici)1097-0215(19970729)72:3%3c398::aid-ijc4%3e3.0.co;2-k
Ogino, T., Moriai, S., Ishida, Y., Ishii, H., Katayama, A., Miyokawa, N., & Ferrone, S. (2007). Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma. International Journal of Cancer, 120(11), 2401–2410. https://doi.org/10.1002/IJC.22334
Lai, H. C., Hsiao, J. R., Chen, C. W., Wu, S. Y., Lee, C. H., Su, I. J., & Chang, Y. (2010). Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines. Virology, 405(2), 464–473. https://doi.org/10.1016/J.VIROL.2010.06.037
Wu, L., Li, C., & Pan, L. (2018). Nasopharyngeal carcinoma: A review of current updates. Experimental and Therapeutic Medicine, 15(4), 3687–3692. https://doi.org/10.3892/ETM.2018.5878/HTML
Liu, Z., Fang, F., Chang, E. T., Adami, H.-O., & Ye, W. (2016). Sibship size, birth order and risk of nasopharyngeal carcinoma and infectious mononucleosis: a nationwide study in Sweden. International Journal of Epidemiology, 45(3), 825–834. https://doi.org/10.1093/ije/dyv038
da Costa, V. G., Marques-Silva, A. C., & Moreli, M. L. (2015). The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: A meta-analysis of observational studies. Systematic Reviews, 4, 46. https://doi.org/10.1186/s13643-015-0037-z
Xue, W.-Q., Wang, T.-M., Huang, J.-W., Zhang, J.-B., He, Y.-Q., Wu, Z.-Y., & Jia, W.-H. (2021). A comprehensive analysis of genetic diversity of EBV reveals potential high-risk subtypes associated with nasopharyngeal carcinoma in China. Virus Evolution, 7(1), 10. https://doi.org/10.1093/ve/veab010
Shimizu, Y., Murakami, N., Mori, T., Takahashi, K., Kubo, Y., Yoshimoto, S., ... Itami, J. (2022). Clinical impact of p16 positivity in nasopharyngeal carcinoma. Laryngoscope Investigative. Otolaryngology, 7, 994–1001. https://doi.org/10.1002/lio2.832
Petrelli, F., Dal Cin, E., Ghidini, A., Carioli, D., Falasca, V., De Stefani, A., & Capriotti, V. (2023). Human papillomavirus infection and non-oropharyngeal head and neck cancers: An umbrella review of meta-analysis. European Archives of Oto-Rhino-Laryngology, 1, 3. https://doi.org/10.1007/s00405-023-08027-4
Stenmark, M. H., McHugh, J. B., Schipper, M., Walline, H. M., Komarck, C., Feng, F. Y., & Carey, T. E. (2014). Nonendemic HPV-positive nasopharyngeal carcinoma: Association with poor prognosis. International journal of radiation oncology, biology, physics, 88(3), 580. https://doi.org/10.1016/J.IJROBP.2013.11.246
Ye, Y.-F., Xiang, Y.-Q., Fang, F., Gao, R., Zhang, L.-F., Xie, S.-H., & Cao, S.-M. (2015). Hepatitis B virus infection and risk of nasopharyngeal carcinoma in southern China. Cancer Epidemiology, Biomarkers & Prevention, 24(11), 1766. https://doi.org/10.1158/1055-9965.EPI-15-0344
Liu, X., Li, X., Jiang, N., Lei, Y., Tang, L. L., Chen, L., & Ma, J. (2014). Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: Analysis of 1301 patients from an endemic area in China. Cancer, 120(1), 68–76. https://doi.org/10.1002/cncr.28377
Ahmed, H. G., Suliman, R. S. A., Ashankyty, I. M., Albieh, Z., & Warille, A. (2018). Role of human Cytomegalovirus in the etiology of nasopharyngeal carcinoma. Journal of Cancer Research and Therapeutics, 14(3), 583–586. https://doi.org/10.4103/0973-1482.176175
Shebl, F. M., Bhatia, K., & Engels, E. A. (2010). Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States. International Journal of Cancer, 126, 2503–2508. https://doi.org/10.1002/ijc.24930
Purgina, B., Pantanowitz, L., & Seethala, R. R. (2011). A review of carcinomas arising in the head and neck region in HIV-positive patients. Pathology Research International, 2011, 1–12. https://doi.org/10.4061/2011/469150
Riley, C. A., Marino, M. J., Hawkey, N., Lawlor, C. M., & McCoul, E. D. (2016). Sinonasal tract inflammation as a precursor to nasopharyngeal carcinoma: A systematic review and meta-analysis. Otolaryngology - Head and Neck Surgery (United States), 154(5), 810–816. https://doi.org/10.1177/0194599816629436
Lin, K., Zeng, Z., Li, X., Chen, W., Lin, D., Xie, S., ... Du, J. (2023). Association between hypertension and Epstein- Barr virus reactivation among the population in a high-risk area for nasopharyngeal carcinoma. Virus Research, 331, 199117. https://doi.org/10.1016/j.virusres.2023.199117
Tseng, K.-S., Lin, C., Lin, Y.-S., & Weng, S.-F. (2014). Risk of head and neck cancer in patients with diabetes mellitus: A retrospective cohort study in Taiwan. JAMA Otolaryngology - Head and Neck Surgery, 140(8), 746–753. https://doi.org/10.1001/jamaoto.2014.1258
Feng, R., Chang, E. T., Liu, Z., Liu, Q., Cai, Y., Zhang, Z., & Ye, W. (2019). Body mass index, body shape, and risk of nasopharyngeal carcinoma: A population-based case–control study in southern China. Cancer Medicine, 8(4), 1835. https://doi.org/10.1002/CAM4.2027
Liu, Q.-Y., Liao, Y., Wu, Y.-X., Diao, H., Du, Y., Chen, Y.-W., & Jia, W.-H. (2023). The oral microbiome as mediator between oral hygiene and its impact on nasopharyngeal carcinoma. Microorganisms, 11, 719. https://doi.org/10.3390/microorganisms11030719
Liao, Y., Zhang, J.-B., Lu, L.-X., Jia, Y.-J., Zheng, M.-Q., Debelius, J. W., & Li, J. (2023). Oral microbiota alteration and roles in Epstein-Barr virus reactivation in nasopharyngeal carcinoma. Microbiology Spectrum, 11, 1. https://doi.org/10.1128/SPECTRUM.03448-22
Hao, Y., Zeng, Z., Peng, X., Ai, P., Han, Q., Ren, B., & Rui Ma, C. (2022). The human oral-nasopharynx microbiome as a risk screening tool for nasopharyngeal carcinoma. Front. Cell. Infect. Microbiol, 12, 1013920. https://doi.org/10.3389/fcimb.2022.1013920
Gupta, V. K., Paul, S., & Dutta, C. (2017). Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Frontiers in Microbiology, 8(1), 237451. https://doi.org/10.3389/FMICB.2017.01162/BIBTEX
Zhong, L., Krummenacher, C., Zhang, W., Hong, J., Feng, Q., Chen, Y., & Zhang, X. (2022). Urgency and necessity of Epstein-Barr virus prophylactic vaccines. Vaccines, 7(1), 159. https://doi.org/10.1038/S41541-022-00587-6
Coghill, A. E., Bu, W., Nguyen, H., Hsu, W. L., Yu, K. J., Lou, P. J., & Cohen, J. I. (2016). High levels of antibody that neutralize b-cell infection of Epstein-Barr virus and that bind ebv gp350 are associated with a lower risk of nasopharyngeal carcinoma. Clinical Cancer Research, 22, 14. https://doi.org/10.1158/1078-0432.CCR-15-2299
Zhu, Q.-Y., Kong, X.-W., Sun, C., Xie, S.-H., Hildesheim, A., Cao, S.-M., & Zeng, M.-S. (2020). Association between antibody responses to Epstein-Barr virus glycoproteins, neutralization of infectivity, and the risk of nasopharyngeal carcinoma. mSphere, 5, 6. https://doi.org/10.1128/msphere.00901-20
Ji, M. F., Sheng, W., Cheng, W. M., Ng, M. H., Wu, B. H., Yu, X., & Cao, S. M. (2019). Incidence and mortality of nasopharyngeal carcinoma: Interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China. Annals of Oncology, 30(10), 1630–1637. https://doi.org/10.1093/annonc/mdz231
Zheng, X. H., Lu, L. X., Li, X. Z., & Jia, W. H. (2015). Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China. Cancer Science, 106(9), 1196–1201. https://doi.org/10.1111/CAS.12718
Yang, X., Dai, W., Kwong, D. L. W., Szeto, C. Y. Y., Wong, E. H. W., Ng, W. T., & Lung, M. L. (2015). Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting. International Journal of Cancer, 136, 4. https://doi.org/10.1002/ijc.29192
King, A. D., Vlantis, A. C., Yuen, T. W. C., Law, B. K. H., Bhatia, K. S., Zee, B. C. Y., & Ahuja, A. T. (2015). Detection of nasopharyngeal carcinoma by MR imaging: Diagnostic accuracy of MRI compared with endoscopy and endoscopic biopsy based on long-term follow-up. American Journal of Neuroradiology, 36, 12. https://doi.org/10.3174/ajnr.A4456
Chan, J. Y. K., Yeung, D. C. M., Vlantis, A. C., Wong, E. W. Y., & Tong, M. C. F. (2018). A meta-analysis of narrowband imaging for the diagnosis of primary nasopharyngeal carcinoma [version 1; referees: 2 approved]. F1000Research, 7, 759. https://doi.org/10.12688/f1000research.15183.1
Yang, X., Wu, J., & Chen, X. (2023). Application of artificial intelligence to the diagnosis and therapy of nasopharyngeal carcinoma. Journal of Clinical Medicine. https://doi.org/10.3390/jcm12093077
Chu, Y. W., Chen, F., Tang, Y., Chen, T., Yu, Y. X., Jin, H. L., & Zeng, X. Y. (2018). Diagnosis of nasopharyngeal carcinoma from serum samples using hyperspectral imaging combined with a chemometric method. Optics Express, 26, 22. https://doi.org/10.1364/oe.26.028661
Colevas, A. D., Yom, S. S., Pfister, D. G., Spencer, S., Adelstein, D., Adkins, D., & Darlow, S. D. (2018). NCCN guidelines ® insights: Head and neck cancers, version 1 .2018 featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network, 16(5), 479–490. https://doi.org/10.6004/jnccn.2018.0026
Liu, Z., Chen, Y., Su, Y., Hu, X., & Peng, X. (2021). Nasopharyngeal carcinoma: Clinical achievements and considerations among treatment options. Frontiers in Oncology, 11, 635737. https://doi.org/10.3389/fonc.2021.635737
Liao, K.-C., Chuang, H.-C., Chien, C.-Y., Lin, Y.-T., Tsai, M.-H., Su, Y.-Y., & Wong, D. (2021). Quality of life as a mediator between cancer stage and long-term mortality in nasopharyngeal cancer patients treated with intensity-modulated radiotherapy. Cancers, 13, 5063. https://doi.org/10.3390/cancers13205063
Ku, P. K. M., Vlantis, A. C., Wong, R. W. M., Hui, T. S. C., Law, T., Ng, L. K. Y., & Tong, M. C. F. (2023). Quality of life and swallowing outcomes after early proactive swallowing rehabilitation by either transcutaneous neuromuscular electrical stimulation or exercise-based swallowing training in patients with nasopharyngeal carcinoma after radiotherapy. Laryngoscope Investigative Otolaryngology, 8(6), 1532–1546. https://doi.org/10.1002/LIO2.1162
Chan, K. C. A., Woo, J. K. S., King, A., Zee, B. C. Y., Lam, W. K. J., Chan, S. L., & Lo, Y. M. D. (2017). Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. The New England Journal of Medicine, 377(6), 513–522. https://doi.org/10.1056/NEJMoa1701717
Yu, X., Ji, M., Cheng, W., Wu, B., Du, Y., & Cao, S. (2018). Assessment of the long-term diagnostic performance of a new serological screening scheme in large-scale nasopharyngeal carcinoma screening. Journal of Cancer, 9(12), 2093–2097. https://doi.org/10.7150/jca.23755
Tan, G. W., Sivanesan, V. M., Abdul Rahman, F. I., Hassan, F., Hasbullah, H. H., Ng, C. C., & Tan, L. P. (2019). A novel and non-invasive approach utilising nasal washings for the detection of nasopharyngeal carcinoma. International Journal of Cancer, 145(8), 2260–2266. https://doi.org/10.1002/IJC.32173
Li, T., Guo, X., Ji, M., Li, F., Wang, H., Cheng, W., & Xia, N. (2018). Establishment and validation of a two-step screening scheme for improved performance of serological screening of nasopharyngeal carcinoma. Cancer Medicine, 7(4), 1458. https://doi.org/10.1002/CAM4.1345
Lam, W. K. J., Jiang, P., Chan, K. C. A., Cheng, S. H., Zhang, H., Peng, W., & Lo, Y. M. D. (2018). Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 115(22), E5115–E5124. https://doi.org/10.1073/PNAS.1804184115/-/DCSUPPLEMENTAL
Lao, T. D., Thieu, H. H., Nguyen, D. H., & Le, T. A. H. (2022). Hypermethylation of the RASSF1A gene promoter as the tumor DNA marker for nasopharyngeal carcinoma. International Journal of Biological Markers, 37, 1. https://doi.org/10.1177/17246008211065472
Zhang, J., Shen, Z., Liu, H., Liu, S., & Shu, W. (2018). Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma. Cancer Management and Research, 10, 2953–2964. https://doi.org/10.2147/CMAR.S171796
Harris, J. P., Saraswathula, A., Kaplun, B., Qian, Y., Chan, K. C. A., Chan, A. T. C., & Pollom, E. (2019). Cost-effectiveness of screening for nasopharyngeal carcinoma among Asian American Men in the United States. Otolaryngology--Head and Neck Surgery, 161(1), 82–90. https://doi.org/10.1177/0194599819832593
Miller, J. A., Le, Q. T., Pinsky, B. A., & Wang, H. (2021). Cost-effectiveness of nasopharyngeal carcinoma screening with Epstein-Barr virus polymerase chain reaction or serology in high-incidence populations Worldwide. Journal of the National Cancer Institute, 113(7), 852–862. https://doi.org/10.1093/JNCI/DJAA198
He, Y. Q., Wang, T. M., Ji, M., Mai, Z. M., Tang, M., Wang, R., & Jia, W. H. (2022). A polygenic risk score for nasopharyngeal carcinoma shows potential for risk stratification and personalized screening. Nature Communications, 13(1), 1–10. https://doi.org/10.1038/s41467-022-29570-4
Jiang, C., Chen, J., Xie, S., Zhang, L., Xiang, Y., Lung, M., & Guan, X. Y. (2018). Evaluation of circulating EBV microRNA BART2–5p in facilitating early detection and screening of nasopharyngeal carcinoma. International Journal of Cancer, 143(12), 3209–3217. https://doi.org/10.1002/IJC.31642
Gao, W., Wong, T. S., Lv, K. X., Zhang, M. J., Tsang, R. K. Y., & Chan, J. Y. W. (2019). Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Head and Neck, 41(3), 780–792. https://doi.org/10.1002/hed.25544
Lu, T., Guo, Q., Lin, K., Chen, H., Chen, Y., Xu, Y., & Pan, J. (2020). Circulating Epstein-Barr virus microRNAs BART7–3p and BART13–3p as novel biomarkers in nasopharyngeal carcinoma. Cancer Science, 111(5), 1711–1723. https://doi.org/10.1111/cas.14381
Coghill, A. E., Pfeiffer, R. M., Proietti, C., Hsu, W. L., Chien, Y. C., Lekieffre, L., & Doolan, D. L. (2018). Identification of a novel, EBV-based antibody risk stratification signature for early detection of nasopharyngeal carcinoma in Taiwan. Clinical cancer research, 24(6), 1305. https://doi.org/10.1158/1078-0432.CCR-17-1929
Gong, R., Yang, C., Abbas, G., Wang, D., Zhang, X., Nie, G., & Ding, H. (2023). Diagnosis of nasopharyngeal carcinoma using an ultrasensitive immunoassay method based on nanoparticles. Nanoscale, 15(7), 3475–3481. https://doi.org/10.1039/D2NR05848K
Juarez, P. D., & Matthews-Juarez, P. (2018). Applying an exposome-Wide (ExWAS) approach to cancer research. Frontiers in Oncology, 8, 313. https://doi.org/10.3389/FONC.2018.00313
Funding
The work was supported by a grant from the Ministry of Higher Education (MOHE) through the Fundamental Research Grant Scheme (FGRS/1/2020/SKK0/UCSI/02/2) and UCSI University Research Excellence and Innovation Grant (REIG-FMS-2020/009).
Author information
Authors and Affiliations
Contributions
ZYS, PYS, and S-CC were involved in the conceptualization and design of the content. ZYS wrote and revised the manuscript. PYS, YYL, and S-CC reviewed and revised the manuscript. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Su, Z.Y., Siak, P.Y., Lwin, Y.Y. et al. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev (2024). https://doi.org/10.1007/s10555-024-10176-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10555-024-10176-9